Exosomes may be used to identify somatic mutations of tumors from liquid biopsies [8, 69], with EGFR and its signaling network proteins frequently detected in exosomes from NSCLC patients, making them potential biomarkers for cancer research and clinical use [75, 76, 78]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.